Latip, Abdul Amin A.

HRN: 24-17-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/27/2023
12/03/2023
IV
95mg
Q24
PCAP C
Waiting Final Action 
11/27/2023
AMPICILLIN 500MG (VIAL)
11/27/2023
12/03/2023
IV
315
Q6
Pcap C
Waiting Final Action 
11/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/28/2023
12/04/2023
IV
350
Q6
Pcap
Waiting Final Action 
11/29/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2023
12/06/2023
IV
65mg
Q8H
Sepsis
Waiting Final Action 
11/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/29/2023
12/06/2023
IV
95mg
Q24H
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: